- About Us
- Editorial Information
- Advertise
- Contact Us
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
Vaccine Development and Manufacturing
Pfizer and BioNTech to Supply Japan and Canada with mRNA-Based COVID-19 Vaccine Candidate
August 07, 2020
The companies have agreements to supply its mRNA-based COVID-19 vaccine to Japan and Canada, pending regulatory approvals in those countries.
J&J in $1-Billion Agreement with US Government for 100 Million Doses of Investigational COVID-19 Vaccine
August 07, 2020
The company is working to ensure broad global access to its COVID-19 vaccine candidate, following approval from regulators.
Sanofi and GSK to Supply COVID-19 Vaccine to US Government and European Union
August 07, 2020
Sanofi and GlaxoSmithKline have been selected to supply the US government and the European Union with millions of doses of their COVID-19 vaccine candidate.
The Impact of SARS-CoV-2 on Biomanufacturing Operations
August 02, 2020
This article presents the results of a survey conducted to gain insight on the impact of the COVID-19 pandemic on biomanufacturing operations.
Intravacc and Celonic Partner for COVID-19 Vaccine Development
July 30, 2020
The companies will combine Intravacc’s OMV delivery platform with S-proteins with Celonic’s CHOvolution mammalian cell expression system to produce B and T-cell responses against SARS-CoV-2.
UK Government Provides Cash Boost for COVID-19 Vaccine Manufacture
July 23, 2020
The UK government is committing a further £100 million (US $127 million) to ensure that there is capability to manufacture a successful COVID-19 vaccine at scale in the UK.
EMA Sets Up Infrastructure to Support Real-World Monitoring of COVID-19 Vaccines
July 23, 2020
The European Medicines Agency has set up an infrastructure to support real-world monitoring of the efficacy and safety of COVID-19 vaccines and treatments.
Novavax and Fujifilm Diosynth Biotechnologies Begin Manufacturing of COVID-19 Vaccine Candidate
July 23, 2020
Fujifilm Diosynth Biotechnologies’ North Carolina site will be used to manufacture Novavax’ NVX‑CoV2373 vaccine candidate for a Phase III clinical trial.
Pfizer and BioNTech Sign Supply Agreement with US Government for Vaccine Candidate
July 22, 2020
Pending approval of the Pfizer and BioNTech mRNA-based vaccine candidate against SARS-COV-2, the companies will supply the US government with an initial 100 million doses.
CureVac Receives Funding, Collaborates with GSK on mRNA and mAbs
July 21, 2020
GSK and CureVac will collaborate on mRNA-based vaccines and mAbs. Separately, the EIB and others provided CureVac with financing for development of its CVnCoV vaccine candidate and expansion of manufacturing.